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Abstract
Oxidative modification of low-density lipoprotein (LDL) turns it into an endogenous ligand recognized by pattern-
recognition receptors. We have demonstrated that minimally oxidized LDL (mmLDL) binds to CD14 and mediates TLR4/MD-
2-dependent responses in macrophages, many of which are MyD88-independent. We have also demonstrated that the
mmLDL activation leads to recruitment of spleen tyrosine kinase (Syk) to TLR4 and TLR4 and Syk phosphorylation. In this
study, we produced a macrophage-specific Syk knockout mouse and used primary Syk
2/2 macrophages in our studies. We
demonstrated that Syk mediated phosphorylation of ERK1/2 and JNK, which in turn phosphorylated c-Fos and c-Jun,
respectively, as assessed by an in vitro kinase assay. c-Jun phosphorylation was also mediated by IKKe. c-Jun and c-Fos
bound to consensus DNA sites and thereby completed an AP-1 transcriptional complex and induced expression of CXCL2
and IL-6. These results suggest that Syk plays a key role in TLR4-mediated macrophage responses to host-generated ligands,
like mmLDL, with subsequent activation of an AP-1 transcription program.
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Introduction
Spleen tyrosine kinase (Syk) is best known as a tyrosine kinase
involved in signaling initiated by B cell receptor, T cell receptor or
Fc receptor. Ligand binding to these receptors leads to recruitment
of signaling proteins with immunoreceptor tyrosine-based activa-
tion motifs (ITAMs). Ensuing phosphorylation of tandem tyrosines
in an ITAM leads to the ITAM binding with Syk via Syk’s tandem
SH2 domains, with subsequent Syk activation. Activated Syk
directly binds to Vav, PLCc, PI3K, and SLP76/SLP65 and
engages a plethora of other signaling intermediates. Resulting
cellular responses range from cytoskeletal changes and ROS
production to cell differentiation, proliferation and survival [1]. In
addition to the SH-2-mediated binding to ITAMs, Syk also binds
to b-integrins via a site distinct from the site of phospho-tyrosine
binding [2,3] and thus, coordinates integrin- and ITAM-
dependent signaling cascades.
We have recently demonstrated, using yeast-two-hybrid and
immunoprecipitation assays, that Syk constitutively binds to the
intracellular domain of toll-like receptor-4 (TLR4) [4,5]. This
binding is further increased and both TLR4 and Syk become
phosphorylated in macrophages stimulated with a host-derived
TLR4 ligand, minimally oxidized low-density lipoprotein
(mmLDL). Further downstream from Syk, mmLDL activates the
Vav-Ras-Raf-MEK1-ERK1/2 pathway, small GTPases Cdc42,
Ras and Rho, and phosphorylates paxillin, which collectively lead
to actin polymerization and extensive membrane ruffling,
culminating in robust macropinocytosis. This mmLDL-induced
and TLR4/Syk-dependent macropinocytosis is suggested to
constitute an important mechanism of excessive lipid accumula-
tion in macrophages, resulting in formation of lipid-laden
macrophage foam cells, a hallmark of atherosclerosis [4–8].
Interestingly, unlike LPS, the mmLDL activation of TLR4 does
not engage MyD88-dependent pathways [4,5]. This makes the Syk-
dependent signaling a central component of mmLDL-induced
macrophage activation via TLR4. In thepresent work,wegenerated
Syk
flox/flox/LysM-Cre mice and performed the majority of experi-
ments with primary macrophages derived from bone marrow in
which Syk expression was reduced by 60–70%, to study the role of
Syk in transcriptional regulation. We demonstrate that Syk regulates
ERK1/2-dependent phosphorylation of c-Fos and JNK/IKKe-
dependent phosphorylation of c-Jun, as well as c-Fos and c-Jun
binding to DNAand AP-1-dependent expression of CXCL2 and IL-
6. These results suggest the role of Syk in TLR4-mediated chronic
inflammation induced by modified host ligands, as it may relate to
inflammation in atherosclerotic lesions induced by oxidized LDL.
Materials and Methods
Ethics Statement
All animal experiments were performed according to the NIH
guidelines and were approved by the Animal Subjects Committee
of the UC San Diego (protocol S04155). Human plasma, used for
LDL isolation, was obtained from normal volunteers according to
a protocol approved by the UC San Diego Human Research
Protection Program (project #071402).
Animals
Syk
flox/flox mice were kindly provided by Alexander Tara-
khovsky from the Rockfeller University [9]. LysM-Cre mice were
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32378purchased from the Jackson Laboratory. Myeloid cell lineage
specific Syk knockdown mice, thereafter referred to as Syk
2/2,
were generated by breeding Syk
flox/flox mice with LysM-Cre mice,
the latter express myeloid cells specific lysozyme 2 promoter-
driven Cre recombinase. Littermate Syk
flox/flox/Cre(2) mice,
thereafter referred to as wild type (WT), were used as a control
in all experiments. In addition, we used MyD88
2/2 mice on the
C57BL6 background [10], kindly provided by Dr. Shizuo Akira
from Research Institute for Microbial Diseases, Osaka University,
and wild type C57BL6 mice as a control.
Cell culture
The majority of experiments were performed with bone marrow





(WT) mice and differentiated with macrophage colony stimulating
factor (L929 conditioned medium) according to published
protocols [11]. Briefly, after mice were sacrificed, tibias and
femurs were dissected and washed with a BMDM growth media
(10% FBS, 50 mg/ml gentamicin and supernatant from L929 cells)
to suspend cells. The cells were placed in 10-cm Petri dishes and
maintained in a humidified 37uC incubator for 5 days to allow
differentiation. Resident peritoneal mouse macrophages were
isolated by peritoneal lavage, without any prior elicitation. Isolated
peritoneal macrophages were plated with DMEM containing 20%
FBS and 50 mg/ml gentamicin. After 3 hours, floating cells were
removed and attached cells were further incubated with 0.5%
FBS/DMEM overnight.
Other cell types in which we achieved Syk loss- or gain-of-
function were used to validate the results obtained with Syk
2/2
BMDM. Chinese hamster ovary-K1 cells (CHO) were from
American Type Culture Collection (ATCC) and maintained in
Dulbecco’s modified Eagle’s medium (DMEM)/F12 supplement-
ed with 10% fetal bovine serum (FBS) and 50 mg/ml gentamicin.
Murine macrophage-like J774A.1 cell lines stably expressing Syk-
specific or scrambled shRNA [5] were cultured in DMEM
supplemented with 10% FBS, 50 mg/ml gentamicin and 0.8 mg/
ml of G418 (Calbiochem) to maintain selection. A murine
fibroblast cell line stably expressing human 15-lipoxygenase [12]
was cultured in 10% FBS and 50 mg/ml gentamicin with 0.5 mg/
ml of G418. Ba/F3 cells stably expressing GFP-TLR4 and Flag-
TLR4 [13,14] were cultured in RPMI1640 medium (Invitrogen)
containing 70 units/ml recombinant murine interleukin-3, 10%
heat-inactivated FBS, 100 units/ml penicillin, and 100 mg/ml
streptomycin (Invitrogen).
Antibodies
Two monoclonal antibodies to mouse TLR4/MD-2 antibodies,
UT12 and UT18, were from eBioscience. An isotype mouse
IgG3k control was from BioLegend Antibodies specific to Syk,
JNK, and IKKe were from Santa Cruz Biotechnology; ERK1/2,
p-ERK1/2, p-JNK, p-c-Jun, p-p65, and GAPDH from Cell
Signaling Technology; GFP from Abcam; and Flag from Sigma-
Aldrich.
LDL preparation and modification
LDL (density=1.019–1.063 g/ml) was isolated from pooled
human plasma by sequential ultracentrifugation [15]. Plasma was
obtained from normal volunteers according to a protocol
approved by the UCSD Human Research Protection Program
(Project #071402). Native and modified LDL preparations were
tested for possible endotoxin contamination using a Limulus
Amoebocyte Lysate kit (Cambrex, Walkersville, MD). Only
preparations with endotoxin ,2.5 pg/ml at a final dilution were
used in experiments. To produce mmLDL, we incubated 50 mg/
ml of native LDL in serum-free DMEM for 18 hours with murine
fibroblasts overexpressing human 15-lipoxygenase [16,17]. To
produce OxLDL, 100 mg/ml of native LDL was incubated with
10 mM CuSO4 for 18 hours at 37uC and then concentrated to
1 mg/ml [18]. The extent of LDL oxidation was assessed by
measuring thiobarbituric acid reactive substances (typically, more
than 30 nmol/mg protein in OxLDL).
Recombinant adenovirus
Recombinant adenovirus expressing Cre recombinase was
kindly provided by Byungkwan Lim (Kirk Knowlton’s lab, UC
San Diego). Recombinant adenoviruses were expanded in
HEK293 cells (from ATCC). Isolated peritoneal macrophages
were infected with recombinant adenovirus expressing Cre
recombinase at 500 multiplicity of infection (MOI) for 48 hours.
A recombinant adenovirus expressing GFP was used as control.
After infection, cells were treated with media or mmLDL (50 mg/
ml) and then cells were harvested.
Real-time quantitative PCR (qPCR)
Total RNA was isolated from 1610
6 cells using RNeasy
columns (Qiagen). Isolated RNA was reverse transcribed using a
First Strand Synthesis kit (Invitrogen) following manufacturer’s
protocol. Probes, primers and reagents for TagMan qPCR were
purchased from Applied Biosystems. qPCR analysis was per-
formed using a Rotor Gene Q thermocycler (Qiagen).
Cytokine ELISA
Cells (0.2610
6) were plated overnight and then incubated with
media alone (DMEM supplemented with 5% lipoprotein-deficient
serum (LPDS)) or in the presence of 50 mg/ml mmLDL for
6 hours or 24 hours. Supernatants were collected and centrifuged
at 10,000 rpm for 5 min to remove floating cells. Levels of MIP-2
(CXCL2) and IL-6 secreted proteins were measured in ELISA
using reagents from R&D Systems.
Chemiluminescent assay for transcription factor/DNA
binding
A chemiluminescent transcription factor/DNA binding assay
was performed as described previously [19]. Briefly, cellular
nuclear extracts were isolated using a Nuclear Extraction kit
(Active Motif). The DNA binding of transcription factors (c-Jun, c-
Fos, and p65) was measured using an Active Motif’s TransAM kit
(Active Motif).
Luciferase reporter assay
CHO cells were transfected with 1 mg of Syk expression plasmid
(kindly provided by Yun Soo Bae, Ewha Womans University,
Korea), 0.2 mg of AP-1-luciferase plasmid (provided by Byungk-
wan Lim and Kirk Knowlton, UC San Diego), and 0.2 mgo fb-
galactosidase plasmid. Thirty six hours after transfection, cells
were stimulated with 50 mg/ml mmLDL or media alone for
6 hours. Luciferase activity was normalized to b-galactosidase
activity.
Immunoblot analysis
Cells were lysed with an ice-cold lysis buffer (50 mM Tris-HCl,
pH 7.5, 1% NP40, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
5m MN a 3VO4, 1 mM NaF, and protease inhibitor cocktail from
Sigma). Protein content was measured by a DC protein assay kit
(BioRad) and equal protein amounts were loaded and run on a 4–
12% PAGE gel (Invitrogen) and then transferred to a PVDF
Syk Regulates AP-1 Dependent Response to mmLDL
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primary antibodies overnight at 4uC, followed by incubation with
secondary antibodies conjugated with HRP for 1 hour at room
temperature. The antibody-bound proteins were detected using a
Super Signal West Dura substrate (Pierce) with an OptiChemHR
Imaging System (UVP).
In vitro kinase assay
J774 cells or BMDM were lysed in 600 ml of cell lysis buffer
(20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1 mM b-glycerophosphate, 1 mM Na3VO4, 1% Triton
X-100, 2.5 mM sodium pyrophosphate, protease inhibitor cock-
tail). Cell lysates were immunoprecipitated with either JNK,
IKKe, or ERK1/2 antibodies overnight at 4uC, and then
incubated further with protein A Sepharose for 1 h at 4uC.
Immune complexes were washed twice with the lysis buffer and
then washed twice with a kinase buffer (20 mM HEPES, pH 7.4,
1 mM MnCl2, 5 mM MgCl2,1 0 m Mb-glycerophosphate,
0.1 mM sodium orthovanadate, 2 mM NaF, 1 mM DTT).
Samples were incubated with 5 mCi of [c-
32P]-ATP (NEN Life
Science) and 2 mg of purified GST-c-Jun (1–79 aa) or GST-c-Fos
(300–380 aa) in 25 ml of kinase buffer for 30 min at 30uC. (The
GST-c-Jun and c-Fos cDNA were kindly provided by Michael
Karin, UC San Diego). The reactions were stopped by adding
LDS sample buffer (Invitrogen), the samples were run on a Nu-
PAGE gel (Invitrogen), and phosphorylated proteins were detected
by autoradiography.
Oil red O staining
BMDM were stained for neutral lipid with Oil Red O and
hematoxylin, as described previously [5]. Briefly, cells were
incubated with media alone or 50 mg/ml mmLDL plus 200 mg/
ml native LDL. After 40 hours, cells were washed, fixed and
stained with Oil Red O and hematoxylin.
Statistical analysis
Graphs represent means 6 standard error from 2–4 indepen-
dent experiments. Significance of differences was calculated using
one-way ANOVA.
Results
Generation of myeloid cell-specific Syk knockout mice
Syk total knockout mice are perinatally lethal [1]. Thus, we
have generated myeloid cell-specific Syk knockout mice by
breeding Syk
flox/flox mice with LysM-Cre mice. mRNA expression
of Syk was undetectable by RT-PCR in BMDM from Syk
2/2
mice (Syk
flox/flox Cre+) compared to WT littermates (Syk
flox/flox
Cre2) (Fig. 1A). Syk protein levels in both peritoneal macrophages
and BMDM were reduced by 60–70% (Fig. 1B; see also Figs. 2B
and S1). Because in our earlier studies with Syk shRNA J774 cells
we demonstrated that Syk knockdown decreased macrophage lipid
accumulation [5], we tested lipid accumulation in Syk
2/2
BMDM. As expected, lipid accumulation in Syk
2/2 BMDM
was dramatically reduced compared to WT BMDM (Fig. 1C).
These results confirm that primary Syk
2/2 macrophages have a
phenotype similar to that observed in a Syk knockdown cell line.
Syk regulates mmLDL-induced activation of AP-1
An initial step in TLR4 activation is ligand-dependent
homodimerization of TLR4. Thus, we tested whether mmLDL
induced dimerization of TLR4, using the established model of Ba/
F3 cells stably expressing GFP-TLR4 and Flag-TLR4 [13,14]. As
shown in Fig. 2A, in cells incubated with mmLDL, GFP-TLR4
pulled down Flag-TLR4, indicating mmLDL-induced TLR4
dimerization. In addition, TLR4 pulled down Syk as well,
reiterating our earlier findings of mmLDL-induced Syk recruit-
ment to TLR4 [4,5]. Blocking TLR4/MD-2 with a specific
antibody diminished mmLDL-induced recruitment of Syk to
TLR4 (Fig. 2A).
Next, we used primary Syk-deficient macrophages to evaluate
Syk-dependent pathways downstream from TLR4. In BMDM,
mmLDL induced phosphorylation of ERK1/2, JNK and c-Jun,
and the Syk deficiency dramatically reduced mmLDL-induced
phosphorylation of these signaling proteins (Fig. 2B). We also
tested Syk
flox/flox peritoneal macrophages infected with a Cre
adenovirus and confirmed that mmLDL-induced ERK1/2
phosphorylation was Syk-dependent (Fig. S1). mmLDL did not
induce phosphorylation of p65 in macrophages (Fig. S2),
validating earlier findings that mmLDL does not activate the
NF-kB pathway [19].
Phosphorylated c-Jun and c-Fos are major components in the
assembly of a heterodimeric AP-1 transcriptional complex. c-Jun is
phosphorylated by JNK and IKKe [20–22]. Indeed, using an in
vitro kinase assay, we demonstrated that both JNK and IKKe
phosphorylated c-Jun (Figs. 2C and S3). Both phosphorylation
events were absolutely dependent on Syk (Fig. 2D). c-Fos is
phosphorylated by activated ERK1/2 and p38 [23,24]. Our
previous studies have shown that mmLDL activates ERK1/2, but
not p38 [5,17]. Thus, we performed an in vitro kinase assay in
lysates precipitated with an ERK1/2 antibody and found that in
mmLDL-activated macrophages, ERK1/2 phosphorylated c-Fos
and that this process was Syk-dependent as well (Fig. 2C,D). Next,
we tested c-Jun and c-Fos binding to consensus DNA sites using a
Figure 1. Reduced Syk expression in macrophages from Syk
flox/
flox/LysM-Cre mice. (A) Total RNA was isolated from BMDM of Syk
flox/
flox/LysM-Cre(2) (WT) and Syk
flox/flox/LysM-Cre(+) (Syk
2/2) mice, and RT-
PCR with Syk and GAPDH primers was performed. (B) Lysates of
resident peritoneal macrophages (PM) and BMDM were run on SDS-
PAGE, transferred to a membrane and immunoblotted with anti-Syk
and anti-GAPDH antibodies. (C) WT and Syk
2/2 BMDM were incubated
with 50 mg/ml mmLDL (to induce macropinocytosis) and 200 mg/ml of
native LDL (lipid carrier) for 40 hours. The cells were stained for neutral
lipid with Oil Red O.
doi:10.1371/journal.pone.0032378.g001
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used cell lysates of Syk
2/2 BMDM and of Syk knockdown J774
cells, with their respective controls. mmLDL induced c-Jun and c-
Fos DNA binding in WT cells, and this effect was completely
inhibited in Syk-deficient macrophages (Fig. 3).
In gain-of-function experiments, CHO cells were transiently
transfected with a Syk expression plasmid (or empty vector) and a
AP-1-Luc reporter. Because CHO cells express endogenous
TLR4/MD2 [25], mmLDL induced a 2-fold increase in AP-1
activity in empty vector-transfected cells. Overexpression of Syk
potentiated mmLDL-induced AP-1 activity and increased it
additional 3-fold (Fig. 4A). Furthermore, Syk expression induced
phosphorylation of JNK and c-Jun in mmLDL-stimulated CHO
cells (Fig. 4B). These results collectively suggest that Syk regulates a
AP-1 transcription program in macrophages.
Syk regulates expression of CXCL2 and IL-6 induced by
mmLDL
Among AP-1 dependent genes, our previous studies identified
Cxcl2 (MIP-2) as one of the best responders to mmLDL activation
in macrophages [4,5,26,27]. Transcription of IL-6 is also AP-1-
dependent, and it has a strong NF-kB component as well [28]. In
experiments shown in Fig. 5, mmLDL induced Cxcl2 and Il-6
mRNA expression both in WT BMDM and in WT J774 cells. The
Syk deficiency in BMDM completely abolished mmLDL-induced
Cxcl2 expression and reduced in half expression of Il-6.
Figure 2. MAP kinases and transcription factors phosphorylation in WT and Syk
2/2 macrophages stimulated with mmLDL and KLA.
(A) Upper blots: Ba/F3 cells stably expressing GFP-TLR4 and Flag-TLR4 were incubated with media or mmLDL (50 mg/ml) for 15 min. Cell lysates were
immunoprecipitated with an anti-GFP antibody and immunoblotted with anti-Flag and anti-GFP antibodies. Lower blots: Ba/F3 cells were
preincubated with 5 mg/ml of an anti-mouse TLR4/MD2 antibody (UT12) or an isotype IgG3k control for 1 hour and then stimulated with mmLDL
(50 mg/ml) for 15 min. Cell lysates were immunoprecipitated with a different anti-mouse TLR4 antibody (UT18) and immunoblotted with anti-Syk and
anti-Flag antibodies. (B) WT and Syk
2/2 BMDM were incubated with media or mmLDL (50 mg/ml) for 15 min. Cell lysates were separated on SDS-
PAGE and immunoblotted with antibodies against Syk, phospho-ERK1/2, phospho-c-Jun, phospho-JNK and GAPDH. (C) In vitro kinase assay in J774
macrophages. Cells were incubated with mmLDL (50 mg/ml) for indicated periods of time and then precipitated with anti-JNK, anti-IKKe and anti-
ERK1/2 antibodies. Endogenous JNK and IKKe kinase activities were determined using GST-c-Jun (1–79 aa) as a substrate, and endogenous ERK1/2
kinase activity was determined using GST-c-Fos (300–380 aa) as a substrate. Protein levels of endogenous JNK, IKKe and ERK1/2 in the same cell
lysates were determined by immunoblot. This experiment informed the optimal stimulation time periods for the experiment in panel D. (D) In vitro
kinase assay in WT and Syk
2/2 BMDM. Cells were treated with media or mmLDL (50 mg/ml) for 30 min (JNK), 5 min (IKKe) or 15 min (ERK1/2). Kinase
activities were determined using the same method as in C.
doi:10.1371/journal.pone.0032378.g002
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CXCL2 (MIP-2) and IL6 protein, we used two types of primary
macrophages: Syk
2/2 BMDM and peritoneal macrophages from
Syk
flox/flox mice infected in vitro with a Cre adenovirus (or with a
GFP adenovirus as a control). In agreement with the mRNA levels
(Fig. 5), mmLDL-induced secretion of CXCL2 was absolutely Syk-
dependent, while secretion of IL-6 was reduced by 40–80% in
Syk-deficient macrophages (Fig. 6). Graphs in Fig. 6 show the
cytokine levels 6 hours after mmLDL stimulation, and graphs in
Fig. S4 show cytokine levels after 24 hours.
Discussion
Using mmLDL as an activator of TLR4-dependent responses in
primary macrophages, in this study we demonstrated that Syk
regulates ERK1/2-dependent phosphorylation of c-Fos and JNK-
and IKKe-dependent phosphorylation of c-Jun, leading to AP-1-
dependent expression of proinflammatory cytokines. Although
involvement of Syk in macrophage responses to LPS have been
reported [29,30], uncovering the mechanism of Syk in TLR4-
dependent transcriptional regulation became possible due to the
fact that mmLDL, unlike LPS, does not induce any apparent
MyD88-mediated responses [4,5]. In this study, we also observed
MyD88-independent phosphorylation of ERK1/2 induced by
mmLDL in macrophages (Fig. S5). The mechanism explaining
lack of MyD88 activation by mmLDL is yet to be found. However,
the use of mmLDL presents a tool for dissecting MyD88-
independent pathways in experiments in which absence of a
strong MyD88/NF-kB component does not mask other pathways
downstream from TLR4.
As we suggested in a recent review article [8], pattern
recognition receptors (PRRs), such as TLR4, likely evolved in
invertebrates and early vertebrates to control homeostasis and
development. Studies from our group and the studies of others
have demonstrated that oxidation-specific epitopes formed in
apoptotic cells and in oxidized lipoproteins (mmLDL is an
example) are recognized by PRRs of innate immunity (summa-
rized in [8]). Responses to these host-derived damage-associated
molecular patterns (DAMPs) involve homeostatic surveillance of
the tissues, characterized by extensive cytoskeletal changes and
macropinocytosis/phagocytosis and moderate secretion of inflam-
matory cytokines. Our results showing mmLDL activation of the
TLR4/Syk signaling pathway, resulting in macropinocytosis [5]
and moderate AP-1 dependent secretion of CXCL2 and IL-6 (this
study) support this hypothesis.
Because many of the same oxidation-specific PRRs also
recognize pathogen-associated molecular patterns (PAMPs), we
speculated that the ability to protect against infectious pathogens
provided a strong secondary selecting pressure for PRRs. For the
purpose of host defense against microbial pathogens, stronger
cellular responses were required to such infectious pathogens than
those resulting from host-derived activation. Indeed, LPS-induced
Figure 3. c-Jun and c-Fos DNA binding in WT and Syk
2/2 macrophages stimulated with mmLDL. BMDM from WT or Syk
2/2 mice (A and
B) and J774 expressing control of Syk-specific shRNA (C and D) were incubated for 1 hour with media or 50 mg/ml mmLDL. Nuclear extracts were
isolated and used in a transcription factor DNA binding plate-based assay. Mean 6 SEM (n=4). *, p,0.05; **, p,0.005 WT vs. Syk
2/2.
doi:10.1371/journal.pone.0032378.g003
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NF-kB transcriptional response. This implies that the intracellular
signaling pathways linking a PRR response to an endogenous
DAMP may be different from those involved in the same PRR
response to microbial PAMPs. This paper provides such an
example showing MyD88-independent signaling via Syk in
mmLDL-activated macrophages, resulting in a relatively muted
cytokine response. However, chronic exposure to increased levels
of oxidation-specific DAMPs, such as mmLDL in hypercholester-
olemic subjects, likely induces low-grade but sustained activation
of PRRs, e.g. TLR4 and its Syk signaling component, and thus,
may contribute to the inflammatory state in atherosclerotic lesions.
Understanding cellular mechanisms of Syk regulation has the
immediate importance because the oral Syk inhibitor fostamatinib
is currently in a phase III clinical trial in patients with rheumatoid
arthritis. Several companies develop a number of new Syk
inhibitors for various clinical applications [1]. Although targeting
Syk is currently designed to benefit conditions with excessively
Figure 4. AP-1 activation in Syk-expressing CHO cells. (A) CHO
cells were transfected with 1 mg Flag-Syk (or empty vector), 200 ng AP-
1-Luc reporter, and 200 ng b-galactosidase plasmid. After 36 hours,
cells were incubated with media or mmLDL for 6 hours and luciferase
activity was measured and normalized to b-galactosidase activity.
Mean6SEM (n=3). *, p,0.05 vector vs. Syk, and media vs. mmLDL. (B)
CHO Cells were transfected with 300 ng empty vector or Flag-Syk. After
24 hours, cells were incubated with mmLDL for 6 hours and cell lysates
were tested for expression of Syk (Flag) and for p-JNK, p-c-Jun and
GAPDH.
doi:10.1371/journal.pone.0032378.g004
Figure 5. mRNA expression of Cxcl2 and Il-6 in WT and Syk
2/2
macrophages stimulated with mmLDL. BMDM from WT or Syk
2/2
mice (A and B) and J774 cells expressing control or Syk-specific shRNA
(C and D) were incubated for 1 hour with media or 50 mg/ml mmLDL.
Total RNA was isolated and expression of Cxcl2 and Il-6 mRNA was
measured by qPCR and normalized to the GAPDH mRNA levels. Mean 6
SEM (n=3). *, p,0.05; **, p,0.005 WT vs. Syk
2/2.
doi:10.1371/journal.pone.0032378.g005
Figure 6. Secretion of CXCL2 (MIP-2) and IL-6 by WT and Syk
2/2
macrophages stimulated with mmLDL. BMDM from WT or Syk
2/2
mice (A and B) and resident peritoneal macrophages from Syk
flox/flox
mice infected with adenovirus expressing GFP or Cre (for 48 hours at
500 MOI) (C and D) were incubated for 6 hours with media or 50 mg/ml
mmLDL. Cell culture media were collected and CXCL2 and IL-6 protein
levels were measured by ELISA. Mean 6 SEM (n=3). *, p,0.05; ****,
p,0.00005 WT vs. Syk
2/2.
doi:10.1371/journal.pone.0032378.g006
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arthritis, allergies, asthma, lupus, etc., our findings and other
reports point to the importance of Syk in regulation of TLR4
responses, particularly by host-derived ligands, and development
of chronic inflammatory diseases, such as atherosclerosis. Indeed,
a very recent report by Hilgendorf et al. [31] demonstrates that
administering fostamatinib attenuates atherosclerosis in Ldlr2/2
mice fed a high-cholesterol diet. The results of the current study as
well as macrophage-specific Syk
2/2 mice generated in our
laboratory will be useful in addressing mechanisms involved in
Syk-dependent chronic inflammation and atherosclerosis.
Supporting Information
Figure S1 ERK1/2 phosphorylation in Adeno-Cre/
Syk
flox/flox macrophages stimulated with mmLDL.
Resident peritoneal macrophages from Syk
flox/flox mice were
infected with adenovirus expressing either GFP or Cre for
48 hours at 500 MOI and then incubated with media or 50 mg/
ml mmLDL for 15, 30 or 60 min. Cell lysates were separated on
Nu-PAGE and immunoblotted with antibodies against Syk,
phospho-ERK1/2 or GAPDH.
(TIF)
Figure S2 Lack of p65 phopshorylation in response to
mmLDL. WT and Syk
2/2 BMDM were incubated with media
or mmLDL (50 mg/ml) for 15 min. Cell lysates were separated on
SDS-PAGE and immunoblotted with antibodies against phospho-
p65 and GAPDH.
(TIF)
Figure S3 Role of JNK, IKKe and ERK1/2 in phosphor-
ylation of c-Jun and c-Fos in mmLDL-stimulated mac-
rophages: Quantification of results presented in Fig. 2C.
In vitro kinase assay in J774 macrophages. Cells were incubated
with mmLDL (50 mg/ml) for indicated periods of time and then
precipitated with anti-JNK, anti-IKKe and anti-ERK1/2 anti-
bodies. Endogenous JNK and IKKe kinase activities were
determined using GST-c-Jun (1–79 aa) as a substrate, and
endogenous ERK1/2 kinase activity was determined using GST-
c-Fos (300–380 aa) as a substrate. Band densities for p-c-Jun and
p-c-Fos were normalized to JNK, IKKe and ERK1/2 in
corresponding blots. Mean6SD from two independent experi-
ments.
(TIF)
Figure S4 Secretion of CXCL2 (MIP-2) and IL-6 by WT
and Syk
2/2 macrophages stimulated with mmLDL.
BMDM from WT or Syk
2/2 mice (A and B) were incubated
for 24 hours with media or 50 mg/ml mmLDL. Cell culture media
were collected and CXCL2 and IL-6 protein levels were measured
by ELISA. Mean 6 SEM from 3 independent experiments.
*, p,0.05; ***, p,0.0005 WT vs. Syk
2/2.
(TIF)
Figure S5 mmLDL-induced phosphorylation of ERK1/2
in WT and MyD88
2/2 macrophages. WT and MyD88
2/2
BMDM (mouse genotypes have been confirmed with PCR) were
incubated with media or mmLDL (50 mg/ml) for 15 min. Cell
lysates were separated on SDS-PAGE and immunoblotted with
antibodies against phospho-ERK1/2 and GAPDH.
(TIF)
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